Physician

Mehul Harish Nagarsheth, MD

According to 2025 Medicare claims, Mehul Nagarsheth, MD (NPI: 1073774774) practices ophthalmology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is EYE CONSULTANTS OF PENNSYLVANIA, PC (NPI: 1033181904; TIN: 231876291) and primary practice location at 19610-1992.

Nagarsheth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,166 traditional Medicare patients, billed 6,488 HCPCS/CPT codes, and received $585,481 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,835 prescription claims across 1,400 beneficiaries totaling $748,816 in drug costs, led by Lumigan (Bimatoprost). DME data shows 31 claims. Open Payments data shows 79 records totaling $13,363. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $348,352 to $585,481. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	800	3,555	$348,352
2016	1,112	4,891	$442,893
2017	1,280	5,707	$501,252
2018	1,319	5,978	$545,316
2019	1,350	5,647	$516,210
2020	1,205	4,711	$418,690
2021	1,159	6,088	$628,733
2022	1,163	5,649	$518,921
2023	1,216	6,183	$565,863
2024	1,166	6,488	$585,481

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	640	3,441	$329,805
2016	937	5,481	$544,495
2017	1,134	7,859	$814,849
2018	1,242	8,851	$980,188
2019	1,360	9,009	$1,056,797
2020	1,326	9,021	$1,033,914
2021	1,376	8,683	$994,802
2022	1,348	8,265	$863,399
2023	1,330	8,115	$864,790
2024	1,400	7,835	$748,816

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	35	35	$2,044
2019	53	53	$3,901
2020	56	57	$3,467
2021	61	61	$4,021
2022	39	40	$2,915
2023	16	16	$772
2024	31	31	$2,139

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,012	1,583	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	193	245	$62
92083	Exam of visual field with extended testing	585	600	$42
92133	Imaging of optic nerve	834	930	$25
92020	Exam of the internal drainage system of eye	410	783	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	435	23,397	$208,480
Combigan	Brimonidine Tartrate/Timolol	256	11,856	$86,028
Vyzulta	Latanoprostene Bunod	98	4,587	$50,528
Rocklatan	Netarsudil Mesylat/Latanoprost	92	2,955	$36,646
Alphagan P	Brimonidine Tartrate	91	4,317	$33,257

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	12	12	$1,171
V2020	Frames, purchases	N	19	19	$969

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$13,363	Glaukos Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mehul Harish Nagarsheth, MD?

Tedicare shows public-source Medicare data for Mehul Harish Nagarsheth, MD (NPI 1073774774), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mehul Harish Nagarsheth, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mehul Harish Nagarsheth, MD?

Mehul Harish Nagarsheth, MD is linked to EYE CONSULTANTS OF PENNSYLVANIA, PC (billing NPI 1033181904) in the available physician profile data.

Does Mehul Harish Nagarsheth, MD have Open Payments data?

Mehul Harish Nagarsheth, MD has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.